Ganeden Biotech Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 29
Employees
  • Latest Deal Type
  • M&A

Ganeden Biotech General Information

Description

Developer of patented probiotic ingredients designed for making over-the-counter probiotic medicines. The company's personal care ingredient is produced through a proprietary fermentation process and contains the optimal combination of naturally derived metabolites enabling its patients in the treatment of abdominal pain and bloating, ulcerative colitis, Crohn's disease and irritable bowel disease.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 5800 Landerbrook Drive
  • Suite 300
  • Mayfield Heights, OH 44124
  • United States
+1 (440) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ganeden Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Oct-2017 0000 Completed Generating Revenue
2. Secondary Transaction - Private 0000 Completed Generating Revenue
1. Later Stage VC (Series A) 05-Nov-2007 $12M $12M 000.00 Completed Generating Revenue
To view Ganeden Biotech’s complete valuation and funding history, request access »

Ganeden Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Ganeden Biotech’s complete cap table history, request access »

Ganeden Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of patented probiotic ingredients designed for making over-the-counter probiotic medicines. The company's pers
Personal Products
Mayfield Heights, OH
29 As of 2017
0000
000000&0 0000

00000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
00000000 00000000
Mumbai, India
0000
0000 0000-00-00
0000000 0000

00000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
000000000000000
Nacka, Sweden
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ganeden Biotech Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OmniActive Health Technologies Private Equity-Backed Mumbai, India 0000 0000000 0000
00000000 Formerly VC-backed Nacka, Sweden 000000&0
0000000000 0000000 Corporate Backed or Acquired Somerset, United Kingdom 000 000000&0
00000 0000000000 0 Formerly PE-Backed East Hanover, NJ 000 0000 00000.
To view Ganeden Biotech’s complete competitors history, request access »

Ganeden Biotech Executive Team (8)

Name Title Board Seat Contact Info
Sean Farmer Co-Founder, Chief Scientific Officer & Director
Joe Bradley Senior Vice President
Gerti Soderquist Marketing Vice President
David Keller Vice President, Scientific Operations
You’re viewing 4 of 8 executive team members. Get the full list »

Ganeden Biotech Board Members (2)

Name Representing Role Since
John Shields Self Chairman 000 0000
To view Ganeden Biotech’s complete board members history, request access »

Ganeden Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ganeden Biotech Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cane Investment Partners Growth/Expansion Minority 000 0000 000000 0
Capital Resource Partners PE/Buyout 000 0000 000000 0
DSM Venturing Corporate Venture Capital Minority 000 0000 000000 0
Fairbridge Venture Partners Venture Capital Minority 000 0000 000000 0
yet2Ventures Venture Capital Minority 000 0000 000000 0
To view Ganeden Biotech’s complete investors history, request access »